Zoe Billinghurst/ LinkedIn
Jun 14, 2026, 15:51
Zoe Billinghurst: Strengthening the Global Rare Blood Disorders Community at EHA 2026
Zoe Billinghurst, Senior Global Brand Director of Rare Blood and Renal Disorders at Novo Nordisk, shared post on LinkedIn:
“Building insights about Rare Blood Disorders – global unmet needs, clinical practice, research advances – steps forward since EHA 2025.
Building on established collaborations and instigating new ones. Amazing and intense week in Stockholm at EHA 2026 with amazing colleagues from Novo Nordisk Rare Disease team.”
Stay updated with Hemostasis Today.
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026
-
Jun 14, 2026, 18:00Tania Lifanova: Another Year of Building Relationships at EHA
-
Jun 14, 2026, 17:59Pratap Kumar: Blood Shortages Are a Health Systems Challenge, Not Just a Donor Shortage
-
Jun 14, 2026, 17:59John Ohd: 3 Great Reasons to Join us Here at EHA 2026
-
Jun 14, 2026, 16:16Andreas Kronbichler: The Intronic Splice-Site Variants in Complement-Mediated Thrombotic Microangiopathy
-
Jun 14, 2026, 16:02Tedros Adhanom Ghebreyesus: WHO and ENHYPEN Celebrating World Blood Donor Day
-
Jun 14, 2026, 16:00Aishee Pal Sadhu: One of the Simplest Ways to Save a Life Is to Donate Blood